-
Sunken Silk Road city reveals Central Asia's lost history
-
EU, China to hold Beijing talks to avert trade war
-
Three years on, Israeli rescuer cannot escape October 7
-
Bolsonaro edges past Lula as nail-biter Brazil vote goes to a run-off
-
Research into weight-loss drugs tipped for Nobel as award week opens
-
Rubio visits Iceland as US boosts Arctic presence
-
US Supreme Court hears bid to shut the door on climate suits
-
Bolsonaro leads Lula as nail-biter Brazil vote goes to a run-off
-
Chourio walk-off single lifts Brewers over Padres
-
Patriots inflict first Bills defeat as Chiefs keep winning
-
Flavio Bolsonaro leads Lula in near-done Brazil vote count
-
Pacific nations take centre stage at 'pre-COP' climate summit
-
Flavio Bolsonaro leads Lula in partial Brazil poll results
-
Ronaldo can return to Portugal team if he wants: coach Jesus
-
Titan FX Launches Second “Dream Beyond Borders 2.0” Brand Commercial Featuring Keisuke Honda
-
Portugal move into Nations League knockout stage, Germany held
-
Patriots inflict first Bills defeat as Rams surge late
-
Ronaldo-less Portugal beat Norway to reach Nations League quarters
-
Brazil's Indigenous back Lula as El Nino fuels forest fires
-
Bosnian Serb strongman claims election win, thanks Trump and Putin
-
Brazil braces for results of election battle between Lula and Bolsonaro
-
Israel wear black armbands in Ireland tie over Hamas attack
-
Indians protest election chief ahead of top court hearing
-
'I fear it could drag on': anxiety takes hold in Ethiopian city wrested from rebels
-
'Verity' kills, Cruise bombs in N. American movie theaters
-
Brazil's Lula and Flavio Bolsonaro face off in knife-edge election
-
Colts top Commanders in NFL London game
-
UK Green party adopts 'Zionism is racism' policy
-
Hundreds of schools to shut Monday as student protests rock France
-
Rio favela residents vote with little hope
-
Three previous two-time Arc de Triomphe winners
-
Evenepoel puts worlds 'disappointment' to bed with European crown
-
'Champion' Daryz wins second successive Arc in fine style
-
Two-time winning Arc trainer Rouget bows out in emotional farewell
-
Daryz wins second successive Prix de l'Arc de Triomphe
-
Battling Djokovic stuns top seed Zverev at China Open
-
England's seven-goal spree sends message to Euro rivals: Kane
-
Spy chief Clayton, the Trump loyalist tech bosses trust on AI
-
Trump confirms national intelligence chief as new AI czar
-
UK's Glastonbury festival tickets sell out in 45 minutes
-
Up to 500 French schools to be totally or partly closed Monday: minister
-
Two dead in Catalonia due to torrential rains: Spanish officials
-
Sydney Roosters edge Knights in tense NRL grand final
-
Verstappen claims first win of year in chaotic Bahrain GP in Malaysia
-
Sabalenka out of China Open in third round, Medvedev into semis
-
Red Bull's Verstappen wins Bahrain Grand Prix in Malaysia
-
Ethiopia controls Tigray capital as regional rivals meet in Egypt
-
أليكس بودي وسفير جمهورية جنوب السودان غوم دومينيك ماتيوك يبحثان في برلين إمكانية إنشاء قنصلية فخرية في بوخارست
-
Ο ΑΛΕΞ ΜΠΟΝΤΙ ΚΑΙ Ο ΠΡΕΣΒΗΣ ΤΗΣ ΔΗΜΟΚΡΑΤΙΑΣ ΤΟΥ ΝΟΤΙΟΥ ΣΟΥΔΑΝ ΓΚΟΥΜ ΝΤΟΜΙΝΙΚ ΜΑΤΙΟΚ ΣΥΖΗΤΟΥΝ ΣΤΟ ΒΕΡΟΛΙΝΟ ΤΟ ΕΝΔΕΧΟΜΕΝΟ ΙΔΡΥΣΗΣ ΕΠΙΤΙΜΟΥ ΠΡΟΞΕΝΕΙΟΥ ΣΤΟ ΒΟΥΚΟΥΡΕΣΤΙ
-
ALEX BODI OCH REPUBLIKEN SYDSUDANS AMBASSADÖR GUM DOMINIC MATIOK DISKUTERAR I BERLIN MÖJLIGHETEN ATT INRÄTTA ETT HONORÄRKONSULAT I BUKAREST
Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
M.Fischer--AMWN